Capital Fund Management (CFM)’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$669K Sell
111,700
-147,300
-57% -$1.11M ﹤0.01% 1813
2025
Q4
$1.86M Sell
259,000
-201,600
-44% -$1.59M 0.01% 1743
2025
Q3
$4.92M Buy
460,600
+28,200
+7% +$277K 0.01% 1269
2025
Q2
$4.19M Buy
432,400
+121,400
+39% +$1.25M 0.01% 1261
2025
Q1
$4.63M Buy
311,000
+200,300
+181% +$3.08M 0.01% 1042
2024
Q4
$1.65M Buy
110,700
+34,900
+46% +$569K ﹤0.01% 1575
2024
Q3
$1.45M Sell
75,800
-11,400
-13% -$236K ﹤0.01% 1577
2024
Q2
$1.81M Sell
87,200
-264,800
-75% -$5.26M 0.01% 1427
2024
Q1
$6.62M Buy
352,000
+85,000
+32% +$1.46M 0.02% 919
2023
Q4
$3.85M Buy
267,000
+47,400
+22% +$645K 0.01% 1225
2023
Q3
$3.81M Buy
219,600
+96,700
+79% +$2.02M 0.01% 1074
2023
Q2
$2.56M Buy
+122,900
New +$2.67M 0.01% 1105

Other funds holding OGN

Capital Fund Management (CFM)'s OGN Position: Q1 2026 in Review

Capital Fund Management (CFM) sold out of Organon & Co (OGN) in Q1 2026, closing a stake of 383,200 shares — an estimated $2.88M sold.

Capital Fund Management (CFM) first reported a position in OGN in Q2 2021 and held it in 4 quarters. The position peaked at $3.89M in Q2 2025. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Capital Fund Management (CFM) reported no remaining Organon & Co position as of Q1 2026 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 383,200 Organon & Co shares in Q1 2026, an estimated $2.88M.
  • Capital Fund Management (CFM) first reported a position in Organon & Co in Q2 2021 and held it in 4 quarters.
  • Capital Fund Management (CFM)'s Organon & Co position peaked at $3.89M in Q2 2025.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.